Starting to think about the 2013-2014 influenza season?

Sanofi Pasteur and VaxServe remain the market leader through 2012-2013 influenza season:
- Sanofi Pasteur: Incomparable track record and experience
- 40 years of experience producing Fluzone vaccine
- Continually meeting customer commitments with quantity requested and delivery times
- Sanofi Pasteur: Unrivaled capacity
- Two US influenza vaccine manufacturing facilities
- Capacity to manufacture up to 150 million total doses of trivalent inactivated vaccine
- Sanofi Pasteur: Unmatched portfolio
- Indication starting at 6 months of age
- Robust pipeline including quadrivalent and universal vaccines
- Continued investigation of new technologies, innovative products, and manufacturing efficiencies
- VaxServe: Specialty distributor that focuses on vaccines
- Relationship with Sanofi Pasteur, manufacturer of Fluzone vaccine
- Representatives available to answer any questions about Fluzone vaccine
Thank you again for another successful influenza season and we look forward to working with you throughout the 2013-2014 season.
VaxServe